Ampio Pharmaceuticals, Inc. (AMPE): Price and Financial Metrics
AMPE Price/Volume Stats
| Current price | $0.43 | 52-week high | $8.30 |
| Prev. close | $0.35 | 52-week low | $0.14 |
| Day low | $0.29 | Volume | 4,060 |
| Day high | $0.48 | Avg. volume | 144,364 |
| 50-day MA | $1.23 | Dividend yield | N/A |
| 200-day MA | $2.62 | Market Cap | 482.38K |
AMPE Stock Price Chart Interactive Chart >
Ampio Pharmaceuticals, Inc. (AMPE) Company Bio
Ampio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of therapies for the treatment of prevalent inflammatory conditions in the United States. It is developing compounds that decrease inflammation by inhibiting specific pro-inflammatory compounds. The company's product pipeline includes Ampion, which is in phase III clinical trial, is an intra-articular injection for the treatment of osteoarthritis of the knee. Ampio Pharmaceuticals, Inc. has collaborative research agreements to explore new clinical indications for its immunomodulatory drug, Ampion. The company is headquartered in Englewood, Colorado.
Latest AMPE News From Around the Web
Below are the latest news stories about AMPIO PHARMACEUTICALS INC that investors may wish to consider to help them evaluate AMPE as an investment opportunity.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on TuesdayIt's time to dive into the biggest pre-market stock movers as we check out all of the hottest trading news for Tuesday morning! |
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on FridayIt's the final day of trading this week and we're starting it with a breakdown of the biggest pre-market stock movers on Friday morning! |
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on ThursdayIt's time for a breakdown of the biggest pre-market stock movers as we check out all of the hottest news on Thursday morning! |
Presenting on the Emerging Growth Conference 64 Day 2 on November 2 Register NowMIAMI, Nov. 01, 2023 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 64th Emerging Growth Conference on November 1st and 2nd, 2023. The Emerging Growth Conference identifies companies in a wide range of growth sectors, with strong management teams, innovative products & services, focused strategy, execution, and the overall potential for long-term growth. Register for the conference here. Submit Questions for any of the presenting |
Ampio Pharmaceuticals to Present at the Emerging Growth ConferenceAmpio Pharmaceuticals, Inc. (NYSE American: AMPE) (the "Company), a pre-revenue stage biopharmaceutical company focused on development of a potential treatment for osteoarthritis as part of its OA-201 program, today announced that its CEO, Michael A. Martino will present in the Emerging Growth Conference on Thursday, November 2, 2023, at 1:10 pm ET. |
AMPE Price Returns
| 1-mo | -47.01% |
| 3-mo | -74.40% |
| 6-mo | -83.71% |
| 1-year | -89.65% |
| 3-year | -99.92% |
| 5-year | -99.74% |
| YTD | -79.02% |
| 2023 | -54.48% |
| 2022 | -97.37% |
| 2021 | -64.15% |
| 2020 | 172.73% |
| 2019 | 47.59% |
Loading social stream, please wait...